Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee/ Workgroup
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, OSG
|
NHLBI, NIAID, NICHD, NIEHS, NIMHD, NINR
|
2011
|
|
Terminology Resources
|
Database
|
FDA
|
NCI
|
2004
|
|
Text 4 Baby Program Evaluation Technical Advisory Group
|
Committee/ Workgroup
|
CDC, FDA, HRSA, OS, SAMHSA
|
NICHD
|
2010
|
|
The Federal TB Task Force
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
FIC, NCATS, NHLBI, NIAAA, NIAID, NICHD, NIDA
|
1991
|
|
The Foundation for the NIH Biomarkers Consortium
|
Committee/ Workgroup
|
CMS, FDA
|
NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS, OD
|
2006
|
|
The Genetic and Rare Diseases Information Center
|
Information Clearinghouse
|
FDA, HRSA
|
NHGRI, NLM
|
2001
|
|
The Health Consequences of Smoking and Involuntary Exposure to Tobacco Smoke: An Update – Workgroup on Mathematical and Statistical Modeling on the Population Impact of Smoking
|
Committee/ Workgroup
|
CDC, FDA, OSG
|
NCI, NIGMS, OD
|
2010
|
|
The NIH Bone Marrow Stromal Cell Transplantation Center
|
Research Initiative
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS
|
2009
|
|
The Pharmacology Research Associate (PRAT) Program
|
Training Initiative
|
FDA
|
NIGMS
|
1965
|
|
The Science of Sex and Gender in Human Health
|
Other
|
FDA
|
OD
|
2006
|
|
The Trans-NIH Rare Diseases Working Group
|
Committee/ Workgroup
|
FDA
|
CC, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2004
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee/ Workgroup
|
FDA
|
NHGRI, OD
|
2009
|
|
Tobacco Control Strategic Planning Committee
|
Committee/ Workgroup
|
CDC, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NIDA
|
2010
|
|
Tox21 Collaboration
|
Research Initiative
|
FDA
|
NHGRI, NIEHS
|
2006
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Nanotechnology Task Force: National Nanotechnology Initiative (NNI) Call For Trans-agency Signature Initiatives
|
Committee/ Workgroup
|
FDA
|
NHLBI, NIBIB, NIDCD, NIDCR
|
2001
|
|
Trans-NIH Plan for HIV-Related Research
|
Committee/ Workgroup
|
CDC, FDA, OS
|
CC, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
1994
|
|
Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC)
|
Committee/ Workgroup
|
FDA
|
NIAID
|
2010
|
|
|